Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
- Citation:
- Blood Cancer J vol 14 (1)
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub-ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 15
- Parents:
- 3823
- Children:
- None
- Pharmas:
- Jansen
- Grants:
- Corr. Author:
- Authors:
- Natalie S. Callander Rebecca Silbermann Jonathan L. Kaufman Kelly N. Godby Jacob Laubach Timothy M. Schmidt Douglas W. Sborov Eva Medvedova Brandi Reeves Binod Dhakal Cesar Rodriguez Saurabh Chhabra Ajai Chari Susan Bal Larry D. Anderson Jr Bhagirathbhai R. Dholaria Nitya Nathwani Parameswaran Hari Nina Shah Naresh Bumma Sarah A. Holstein Caitlin Costello Andrzej Jakubowiak Tanya M. Wildes Robert Z. Orlowski Kenneth H. Shain Andrew J. Cowan Huiling Pei Annelore Cortoos Sharmila Patel Thomas S. Lin Smith Giri Luciano J. Costa Saad Z. Usmani Paul G. Richardson Peter M. Voorhees
- Networks:
- CA043, CA249, CA824, FL065, LAPS-AL002, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, LAPS-TN008, LAPS-TX011, LAPS-TX035, LAPS-UT003, LAPS-WI013, LAPS-WI020, NC002, NE003, NEWMEXICO, OR013
- Study
- AFT-29 (GRIFFIN)
- Multiple Studies, or Legacy Studies in Alliance Study:
- MASTER
- Phases:
- 2, 2
- Keywords: